New Blood Test Pinpoints Parkinson's Disease Through Mitochondrial DNA Damage

Industry Updates
Written By Kaleidoscope Management Group
 
 
 

In a recent study published in the journal Science Translational Medicine, researchers investigate the potential of mitochondrial deoxyribonucleic acid (mtDNA) injury as a serological marker for Parkinson's disease (PD) using the novel Mito DNADX test.

The study found that people with REM sleep behavior disorder (RBD), a sleep disorder that may be a predictor of Parkinson’s disease, frequently exhibit mitochondrial abnormalities.

Read more about the mechanism of cellular abnormalities in these patients:

 
Kaleidoscope Management Group
Previous

High-Intensity Exercise Can Reverse Neurodegeneration in Parkinson’s Disease
Next

RBD Behavior Spectrum